Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues

Cancer Research

Volumn 61, Issue 21, 2001, Pages 7803-7810

  Tu, Hong ^a   Bonura, Celestino ^a,b   Giannini, Carlo ^a   Mouly, Héléne ^a   Soussan, Patrick ^a   Kew, Michael ^c   Paterlini Bréchot, Patrizia ^a   Bréchot, Christian ^a   Kremsdorf, Dina ^a  

^a INSERM   (France)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS X PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CASE REPORT; CELL PROLIFERATION; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; GENE DELETION; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; NONHUMAN; ONCOGENE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; GENES, MYC; GENES, RAS; GROWTH INHIBITORS; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFECTION;

EID: 0035502957     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Hepatitis B virus in hepatocarcinogenesis
2. Transactivators of HBV, signal transductiontumorigenesis
3. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication
4. Hepatitis B virus. X protein and p53 tumor suppressor interactions in the modulation of apoptosis
5. The hepatitis B virus HBx protein inhibits caspase 3 activity
6. Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NFκB
7. Hepatitis B virus, X protein inhibits transforming growth factnr-/3 factor-p-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway
8. Hepatitis B virus, X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx
9. The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines
10. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro
11. X-gene product of hepatitis B virus induces apoptosis in liver cells
12. Role of NF-κB and myc proteins in apoptosis induced by hepatitis B virus HBx protein
13. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor α
14. The hepatitis B virus X gene induces p53-mediated programmed cell death
15. Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death
16. Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesis
17. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts
18. Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis
19. Intracellular localization of the hepatitis B virus HBx protein
20. Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential
21. HBx gene of hepatitis B virus induces liver cancer in transgenic mice
22. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein
23. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse N1H3T3 cells
24. In vitro tumorigenicity of hepatitis B virus DNA and HBx protein
25. Properties of tumour suppressor p53 in murine hepatocyte lines transformed by hepatitis B virus X protein
26. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p 53 mutant equivalent to human codon 249
27. Differential immediate early gene expression in conditional hepatitis B virus pX-transforming versus nontransforming hepatocyte cell lines
28. Hepatitis B virus X protein transcription activation domains are neither required nor sufficient for cell transformation
29. Long-term expression of the hepatitis B virus core-e- and X-proteins does not cause pathologic changes in transgenic mice
30. Recognition efficiency of the hepatitis B virus polyadenylation signals is tissue specific in transgenic mice
31. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice
32. In vivo activity of the hepatitis B virus core promoter: Tissue specificity and temporal regulation
33. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma
34. The value of hepatitis B x antigen as a prognostic marker in the development of hepatocellular carcinoma
35. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer
36. Hepadna virus integration generates virus-cell cotranscripts carrying 3' truncated X genes in human and woodchuck liver tumors
37. Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance
38. Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma
39. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state
40. Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas
41. Transactivation of cellular promoters by an integrated hepatitis B virus DNA
42. Integrated hepatitis B virus X and 3′ truncated preS/S sequences derived from human hepatomas encode functionally active transactivators
43. Analysis of integrated hepatitis B virus DNA and flanking cellular sequences in a childhood hepatocellular carcinoma
44. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma
45. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: Comparative analysis of 40 full-length isolates
46. High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers
47. Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma
48. A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome
49. Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM
50. Oncogenic activation of a human cyclin A2 targeted to the endoplasmic reticulum upon hepatitis B virus genome insertion
51. Transformation of primary rat embryo cells
52. Integration of hepatitis B virus: Analysis of unoccupied sites
53. Amplification and rearrangement in hepatoma cell DNA associated with integrated hepatitis B virus DNA
54. HBV DNA integration and insertional mutagenesis
55. Identification of three essential regions of hepatitis B virus X protein fortrans-activation function
56. A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function
57. Integration of hepatitis B virus DNA through a mutational hot spot within the cohesive region in a case of hepatocellular carcinoma
58. Analysis of integrated hepatitis B virus DNA and flanking cellular sequence by inverse polymerase chain reaction